Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-23T00:32:48.017Z Has data issue: false hasContentIssue false
  • English
  • Français

Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer

Published online by Cambridge University Press:  21 August 2013

S. Walker ,
J. Walker ,
G. Richardson ,
S. Palmer ,
Q. Wu ,
S. Gilbody ,
P. Martin ,
C. Holm Hansen ,
A. Sawhney  and
G. Murray
...Show all authors
S. Walker*
Affiliation:
Centre for Health Economics, University of York, Heslington, York, UK
J. Walker
Affiliation:
Psychological Medicine Research, University of Oxford Department of Psychiatry, Warneford Hospital, Oxford, UK
G. Richardson
Affiliation:
Centre for Health Economics, University of York, Heslington, York, UK
S. Palmer
Affiliation:
Centre for Health Economics, University of York, Heslington, York, UK
Q. Wu
Affiliation:
Department of Health Sciences, University of York, Heslington, York, UK
S. Gilbody
Affiliation:
Department of Health Sciences, University of York, Heslington, York, UK
P. Martin
Affiliation:
Psychological Medicine Research, University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK
C. Holm Hansen
Affiliation:
Psychological Medicine Research, University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK
A. Sawhney
Affiliation:
Psychological Medicine Research, University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK
G. Murray
Affiliation:
University of Edinburgh Centre for Population Health Sciences, Edinburgh, UK
M. Sculpher
Affiliation:
Centre for Health Economics, University of York, Heslington, York, UK
M. Sharpe
Affiliation:
Psychological Medicine Research, University of Oxford Department of Psychiatry, Warneford Hospital, Oxford, UK
*
*Address for correspondence: S. Walker, M.Sc., Centre for Health Economics, University of York, Heslington, York YO10 5DD, UK. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Co-morbid major depression occurs in approximately 10% of people suffering from a chronic medical condition such as cancer. Systematic integrated management that includes both identification and treatment has been advocated. However, we lack information on the cost-effectiveness of this combined approach, as published evaluations have focused solely on the systematic (collaborative care) treatment stage. We therefore aimed to use the best available evidence to estimate the cost-effectiveness of systematic integrated management (both identification and treatment) compared with usual practice, for patients attending specialist cancer clinics.

Method

We conducted a cost-effectiveness analysis using a decision analytic model structured to reflect both the identification and treatment processes. Evidence was taken from reviews of relevant clinical trials and from observational studies, together with data from a large depression screening service. Sensitivity and scenario analyses were undertaken to determine the effects of variations in depression incidence rates, time horizons and patient characteristics.

Results

Systematic integrated depression management generated more costs than usual practice, but also more quality-adjusted life years (QALYs). The incremental cost-effectiveness ratio (ICER) was £11 765 per QALY. This finding was robust to tests of uncertainty and variation in key model parameters.

Conclusions

Systematic integrated management of co-morbid major depression in cancer patients is likely to be cost-effective at widely accepted threshold values and may be a better way of generating QALYs for cancer patients than some existing medical and surgical treatments. It could usefully be applied to other chronic medical conditions.

Keywords

Cancercollaborative carecost-effectivenessdepression
Type
Original Articles
Information
Psychological Medicine , Volume 44 , Issue 7 , May 2014 , pp. 1451 - 1460
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Archer, J, Bower, F, Gilbody, S, Lovell, K, Richards, D, Gask, L, Dickens, C, Coventry, P (2012). Collaborative care for depression and anxiety problems. Cochrane Database of Systematic Reviews. Issue 10, Art. No. CD006525.Google Scholar
Arroll, B, Elley, CR, Fishman, T, Goodyear-Smith, FA, Kenealy, T, Blashki, G, Kerse, N, MacGillivray, S (2009). Antidepressants versus placebo for depression in primary care. Cochrane Database of Systematic Reviews. Issue 3, Art No. CD007954.CrossRefGoogle ScholarPubMed
BMA/RPS (2010). British National Formulary. British Medical Association the Royal Pharmaceutical Society. Pharmaceutical Press: London.Google Scholar
Cape, J, McCulloch, Y (1999). Patients' reasons for not presenting emotional problems in general practice consultations. British Journal of General Practice 49, 875–879.Google Scholar
Cepoiu, M, McCusker, J, Cole, MG, Sewitch, M, Belzile, E, Ciampi, A (2008). Recognition of depression by non-psychiatric physicians: a systematic literature review and meta-analysis. Journal of General Internal Medicine 23, 25–36.Google Scholar
Coventry, P, Hays, R, Dickens, C, Bundy, C, Garret, C, Cherrington, A, Chew-Graham, CA (2011). Talking about depression: a qualitative study of barriers to managing depression in people with long term conditions in primary care. BMC Family Practice 12, 10.Google Scholar
Curtis, L (2011). Unit Costs of Health and Social Care 2011. Personal Social Services Research Unit (PSSRU), University of Kent: Canterbury.Google Scholar
Department of Health (2011 a). NHS Reference Costs 2009–2010. Department of Health: London.Google Scholar
Department of Health (2011 b). Ten things you need to know about long term conditions (www.dh.gov.uk/en/Healthcare/Longtermconditions/tenthingsyouneedtoknow/index.htm). Accessed 12 December 2011.Google Scholar
Drummond, M, Sculpher, MJ, Torrance, GW, O'Brien, BJ, Stoddart, GL (2005). Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press: Oxford.Google Scholar
Fann, J, Ell, K, Sharpe, M (2012). Integrating psychosocial care into cancer services. Journal of Clinical Oncology 30, 1160–1177.Google Scholar
First, M, Gibbon, M, Spitzer, R, Williams, J (1996). User's Guide for the SCID-I, Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version. Biometrics Research Department, New York State Psychiatric Institute: New York.Google Scholar
Geddes, J, Carney, S, Davies, C, Furukawa, T, Knupfer, D, Frank, E, Goodwin, G (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review Lancet 361, 653–661.Google Scholar
Gilbody, S, Sheldon, T, Wessely, S (2006). Should we screen for depression? British Medical Journal 332, 1027–1030.Google Scholar
Gilbody, SM, House, AO, Sheldon, TA (2001). Routinely administered questionnaires for depression and anxiety: systematic review. British Medical Journal 322, 406–409.CrossRefGoogle ScholarPubMed
Greenberg, DB (2004). Barriers to the treatment of depression in cancer patients. Journal of the National Cancer Institute. Monographs 32, 127–135.Google Scholar
Gunn, J, Diggens, J, Hegarty, K, Blashki, G (2006). A systematic review of complex system interventions designed to increase recovery from depression in primary care. BMC Health Services Research 6, 88.CrossRefGoogle ScholarPubMed
Hopko, DR, Lejuez, CW, Ruggiero, KJ, Eifert, GH (2003). Contemporary behavioral activation treatments for depression: procedures, principles, and progress. Clinical Psychology Review 23, 699–717.Google Scholar
Katon, W (2012). Collaborative depression care models: from development to dissemination. American Journal of Preventive Medicine 42, 550–552.CrossRefGoogle ScholarPubMed
Katon, W, Ciechanowski, P (2002). Impact of major depression on chronic medical illness. Journal of Psychosomatic Research 53, 859–863.Google Scholar
Katon, W, Russo, J, Lin, EH, Schmittdiel, J, Ciechanowski, P, Ludman, E, Peterson, D, Young, B, Von Korff, M (2012). Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Archives of General Psychiatry 69, 506–514.Google Scholar
Kroenke, K, Spitzer, RL, Williams, JB (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine 16, 606–613.Google Scholar
Ladapo, J, Shaffer, J, Fang, X, Ye, S, Davidson, K (2012). Cost-effectiveness of enhanced depression care after acute coronary syndrome: results from the coronary psychosocial evaluation studies randomized controlled trial. Archives of Internal Medicine 172, 1682–1684.Google Scholar
Mitchell, A, Vaze, A, Rao, S (2009). Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 374, 609–619.CrossRefGoogle ScholarPubMed
Moussavi, S, Chatterji, S, Verdes, E, Tandon, A, Patel, V, Ustun, B (2007). Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370, 851–858.Google Scholar
Mynor-Wallis, L (2005). Problem-solving Treatment for Anxiety and Depression: A Practical Guide. Oxford University Press: Oxford.Google Scholar
NCCMH (2010). Depression: The Treatment and Management of Depression in Adults. National Collaborating Centre for Mental Health. British Psychological Society: Leicester, UK.Google Scholar
NICE (2008). Guide to the methods of technology appraisal. (http://www.nice.org.uk/media/b52/a7/tamethodsguideupdatedjune2008.pdf). National Institute for Health and Care Excellence: London.Google Scholar
NICE (2009 a). NICE Guideline Depression: the treatment and management of depression in adults (updated edition) Clinical Guideline 90. (http://www.nice.org.uk/nicemedia/live/12329/45896/45896.pdf). National Institute for Health and Care Excellence: London.Google Scholar
NICE (2009 b). Depression in adults with a chronic physical health problem. Clinical Guideline 91. (http://www.nice.org.uk/nicemedia/live/12327/45909/45909.pdf). National Institute for Health and Care Excellence: London.Google Scholar
Nutting, PA, Rost, K, Smith, J, Werner, JJ, Elliot, C (2000). Competing demands from physical problems: effect on initiating and completing depression care over 6 months. Archives of Family Medicine 9, 1059–1064.Google Scholar
Parkin, DM, Bray, F, Ferlay, J, Pisani, P (2001). Estimating the world cancer burden: Globocan 2000. International Journal of Cancer 94, 153–156.Google Scholar
Paulden, M, Palmer, S, Hewitt, C, Gilbody, S (2009). Screening for postnatal depression in primary care: cost effectiveness analysis. British Medical Journal 339, b5203.CrossRefGoogle ScholarPubMed
Pignone, M, Gaynes, B, Rushton, J, Mills Burchell, C, Orleans, C, Mulrow, C, Lohr, K (2002). Screening for depression in adults: a summary of the evidence for the US Preventive Services Task Force. Annals of Internal Medicine 136, 765–776.Google Scholar
Pinquart, M, Duberstein, PR (2010). Depression and cancer mortality: a meta-analysis. Psychological Medicine 40, 1797–1810.Google Scholar
Revicki, DA, Wood, M (1998). Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. Journal of Affective Disorders 48, 25–36.Google Scholar
Sharpe, M, Strong, V, Allen, K, Rush, R, Postma, K, Tulloh, A, Maguire, P, House, A, Ramirez, A, Cull, A (2004). Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. British Journal of Cancer 90, 314–320.Google Scholar
Simon, GE, Katon, WJ, Lin, EH, Rutter, C, Manning, WG, Von Korff, M, Ciechanowski, P, Ludman, EJ, Young, BA (2007). Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Archives of General Psychiatry 64, 65–72.Google Scholar
Sobocki, P, Ekman, M, Agren, H, Jonsson, B, Rehnberg, C (2006). Model to assess the cost-effectiveness of new treatments for depression. International Journal of Technology Assessment in Health Care 22, 469–477.Google Scholar
Strong, V, Waters, R, Hibberd, C, Murray, G, Wall, L, Walker, J, McHugh, G, Walker, A, Sharpe, M (2008). Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet 372, 40–48.Google Scholar
U.S. Preventive Services Task Force (2009). Screening for depression in adults: U.S. preventive services task force recommendation statement. Annals of Internal Medicine 151, 784–792.Google Scholar
Valenstein, M, Vijan, S, Zeber, JE, Boehm, K, Buttar, A (2001). The cost-utility of screening for depression in primary care. Annals of Internal Medicine 134, 345–360.Google Scholar
Walker, J, Postma, K, Mchugh, GS, Rush, R, Coyle, B, Strong, V, Sharpe, M (2007). Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. Journal of Psychosomatic Research 63, 83–91.Google Scholar
Walker, J, Sharpe, M (2009). Depression care for people with cancer: a collaborative care intervention. General Hospital Psychiatry 31, 436–441.Google Scholar
Walters, S, Nur, U, Rachet, B, Gordon, E, Jakomis, N, Edgar, G, Coleman, M (2010). Cancer survival in England: one-year and five-year survival for 21 common cancers, by sex and age (http://www.ons.gov.uk/ons/rel/cancer-unit/cancer-survival-rates/patients-diagnosed-2003-2007–followed-up-to-2008/sb1.pdf). Office for National Statistics: Newport.Google Scholar
Zigmond, AS, Snaith, RP (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67, 361–370.CrossRefGoogle ScholarPubMed
Supplementary material: Image

Walker Supplementary Material

Image

Download Walker Supplementary Material(Image)
Image 33.2 KB
Supplementary material: Image

Walker Supplementary Material

Image

Download Walker Supplementary Material(Image)
Image 94.1 KB
Supplementary material: File

Walker Supplementary Material

Figures

Download Walker Supplementary Material(File)
File 24.1 KB